排序方式: 共有65条查询结果,搜索用时 15 毫秒
21.
Frontotemporal lobar degeneration (FTLD) is a heterogeneous group including both sporadic and familial diseases, characterized by a macroscopic alteration. It may correspond to various cognitive syndromes: behavioral variant of frontotemporal dementia (bvFTD), progressive nonfluent aphasia, and semantic dementia. The neuropathologic classification is now based on identification of the protein that accumulates in neurons and glia: Tau, TAR DNA Binding Protein 43 (TDP-43), and FUsed in Sarcoma (FUS). The disorders in which the corresponding proteins accumulate have been named FTLD-Tau, FTLD-TDP, and FTLD-FUS. FTLD-Tau includes sporadic cases (e.g. Pick's disease) and Tau mutations. FTLD-TDP are subdivided within four types (A, B, C, D) according to the shape and distribution of TDP-43 positive lesions within the associative frontal cortex. The FTLD-FUS group includes atypical FTLD with ubiquitinated lesions (FTLD-U), Neuronal Intermediate Filament Inclusion Disease (NIFID) and Basophilic Inclusion Body Disease (BIBD). 相似文献
22.
Parastoo Momeni Karen DeTucci Richard E. Straub Daniel R. Weinberger Peter Davies Jordan Grafman 《Neurocase》2013,19(3):273-279
ABSTRACTPhenylketonuria (PKU) is an autosomal recessive metabolic disorder due to mutations in the phenylalanine hydroxylase (PAH) gene, which converts phenylalanine (PHE) to tyrosine. Although it is principally a childhood disorder, in rare cases, the first signs of PKU may develop in late adulthood resembling common neurological diseases. Here we report a 59-year-old, previously normal functioning man who was admitted with blurred vision, cognitive problems, and gait difficulty that began 8 months before. He had brisk reflexes and left side dominant parkinsonism. His Mini-Mental State Examination (MMSE) score was 25/30, and neuropsychological evaluation revealed a dysexecutive syndrome with simultanagnosia and constructional apraxia. His Clinical Dementia Rating score (CDR) was 1. Cranial MRI revealed bilateral diffuse hyperintense lesions in parietal and occipital white matter in T2, fluid-attenuated inversion recovery, and diffusion weighted images. Diagnostic workup for rapidly progressive dementias was all normal except PHE level which was found to be highly elevated (1075 μmol/L, normal 39–240 μmol/L) with normal tyrosine level (61.20 μmol/L, normal 35–100 μmol/L). Three months after PHE-restricted diet, his cognitive impairment and signs of parkinsonism significantly improved, with MRI scan unchanged. This case demonstrates that late-onset PKU is a rare, treatable cause of rapidly progressive dementia and parkinsonism with certain constellations such as consanguinity and white matter abnormalities (WMAs) in imaging. 相似文献
23.
Livia Bernardi Francesca Frangipane Nicoletta Smirne Rosanna Colao Gianfranco Puccio Sabrina A.M. Curcio Maria Mirabelli Raffaele Maletta Maria Anfossi Maura Gallo Silvana Geracitano Maria Elena Conidi Raffale Di Lorenzo Alessandra Clodomiro Chiara Cupidi Sandra Marzano Francesco Comito Vincenzo Valenti Maria Angela Zirilli Mahdi Ghani Zhengrui Xi Christine Sato Danielle Moreno Annelisa Borelli Rosa Anna Leone Peter St. George-Hyslop Ekaterina Rogaeva Amalia C. Bruni 《Neurobiology of aging》2012
The objectives of this study were to estimate frontotemporal dementia (FTD) prevalence, identify FTD-related mutations, and correlate FTD phenotype with mutations in a Southern Italian population. The study population consisted of subjects ≥ 50 years of age residing in the Community of Biv. on January 1, 2004, and a door-to-door 2-phase design was used. Genetic and biochemical analyses were done on samples collected from 32 patients. Prevalence rates were 0.6 for Alzheimer's disease, 0.4 for vascular dementia (VD), 3.5 for FTD, 0.2 for Parkinson dementia, and 1.2 for unspecified dementia. Three GRN (1 known and 2 novel) mutations with reduced plasma protein levels were found associated to 3 distinct phenotypes (behavioral, affective, and delirious type). We report an unusually high FTD prevalence in the investigated population, but a low prevalence of Alzheimer's disease. We confirm the heterogeneity of FTD phenotype associated with different GRN mutations. 相似文献
24.
目的:探讨血清颗粒蛋白前体(progranulin,PGRN)、糖类抗原19-9(CA19-9)、癌胚抗原(CEA)、甲胎蛋白(AFP)检测在鉴别胆管良恶性病变中的价值。方法:检测31例术后病理证实的胆管癌患者、30例胆管良性病变患者及10名健康人的血清PGRN、CA19-9、CEA、AFP。结果:血清PGRN、CA19-9、CEA水平在胆管癌患者、胆管良性病变患者及正常人中依次降低(P<0.01)。胆管癌患者及胆管良性病变患者的血清AFP较正常人均明显升高(P0.05)。PGRN鉴别胆管良恶性病变的灵敏度最高(83.87%),而CA19-9的特异度最高(100%)。联合检测采用并联试验可进一步提高诊断的灵敏度和诊断效能。结论:PGRN有作为胆管肿瘤标志物的潜力,与CA19-9、CEA、AFP联合检测可有较高的诊断价值。 相似文献
25.
Ricardo R. Guerra Leonid Kriazhev Francisco J. Hernandez-Blazquez 《Growth factors (Chur, Switzerland)》2013,31(4):280-285
The growth factor progranulin (granulin–epithelin precursor, PC-derived growth factor or acrogranin) regulates proliferation and migration and is implicated in cancer, development, wound repair and neurodegenerative diseases. Under most conditions fibroblasts do not express progranulin in vivo, however its expression is activated following wounding. We hypothesised that progranulin is part of a fibroblast stress response. Fibroblasts in culture were exposed to two physiologically and clinically relevant microenvironmental stresses; hypoxia (1% oxygen) and acidosis, both of which increase progranulin expression. The greatest increases occurred when hypoxia and acidosis were combined. Increased progranulin expression is not a direct response to apoptosis since it occurred under conditions of pH and hypoxia under which cell viability remained high. Low concentrations of progranulin (2 nM) protected fibroblasts from apoptosis induced by extreme acidosis (pH 5.0 and 4.0). We propose that progranulin is part of a fibroblast stress response and is cytoprotective to acidotic stress. 相似文献
26.
Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We sought to determine whether serum progranulin levels are altered in patients with biopsy-proven NAFLD and if they are associated with their clinical, biochemical, and histological characteristics.
Subjects and methods: We measured serum progranulin levels in 95 patients with biopsy-proven NAFLD and 80 age- and sex-matched controls. The potential associations between progranulin and the characteristics of NAFLD patients were examined by multiple linear regression analysis.
Results: Serum progranulin levels were significantly higher in NAFLD patients (34 ± 13 ng/mL) than in controls (28 ± 7 ng/mL, P <
0.001). In NAFLD patients, serum progranulin levels were associated with lipid levels and the degree of hepatic fibrosis. After adjustment for potential confounders, serum progranulin remained an independent predictor of the degree of hepatic fibrosis in NAFLD patients (β = 0.392; t =2.226, P < 0.01).
Conclusions: Compared with controls, NAFLD patients have higher serum progranulin concentrations, which are closely associated with lipid values and the extent of hepatic fibrosis. 相似文献
27.
Pickering-Brown SM 《Acta neuropathologica》2007,114(1):39-47
Frontotemporal lobar degeneration is the term used to describe the non-Alzheimer clinical syndromes of frontotemporal dementia,
semantic dementia and progressive non-fluent aphasia, regardless of the underlying neuropathological features. Considerable
progress has been made in recent years in our understanding of the aetiology of this disorder, notably the identification
of mutations in tau and progranulin genes, both on chromosome 17q21. Mutations in tau appear to affect the ability of tau
to bind microtubules and/or increase this protein’s ability to form fibrils. In contrast, progranulin mutations cause haploinsufficiency
leading to TDP-43 accumulation. These genes collectively account for 10–20% of FTLD. However, it is clear that much remains
to be discovered before our knowledge of this heterogeneous condition is complete. 相似文献
28.
Mackenzie IR 《Acta neuropathologica》2007,114(1):49-54
Mutations in the progranulin gene (PGRN), on chromosome 17q21, have recently been identified as a major cause of familial frontotemporal dementia (FTD). These cases
have a characteristic pattern of neuropathology that is a distinct subtype of frontotemporal lobar degeneration with ubiquitinated
inclusions (FTLD-U), with lentiform neuronal intranuclear inclusions being a consistent feature. There is no abnormal accumulation
of PGRN protein in the brain and immunohistochemical and biochemical analysis indicates that the ubiquitinated pathological
protein is TDP-43. In these families, FTD is inherited in an autosomal dominant fashion with high penetrance. The clinical
phenotype is usually a combination of behavioural abnormality and language disturbance that is most often a form of primary
progressive aphasia. Mild parkinsonism is common but motor neuron disease is notably rare. Marked variation in the disease
course and clinical features are common, not only between families with different mutations, but also within individual families.
This degree of clinical variability makes it difficult to predict which cases of familial FTD will turn out to have a PGRN
mutation. 相似文献
29.
Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy 总被引:1,自引:0,他引:1
Thorpe JR Tang H Atherton J Cairns NJ 《Journal of neural transmission (Vienna, Austria : 1996)》2008,115(12):1661-1671
TAR DNA-binding protein of 43 kDa (TDP-43) is a major component of the pathological inclusions of frontotemporal lobar degeneration
with TDP-43 proteinopathy, also called FTLD with ubiquitin-positive, tau-negative inclusions (FTLD-U), and motor neuron disease
(MND). TDP-43 is predominantly expressed in the nucleus and regulates gene expression and splicing. In FTLD with TDP-43 proteinopathy,
neuronal inclusions present variably as cytoplasmic inclusions (NCIs), dystrophic neurites (DNs), and intranuclear inclusions
(NIIs), leading to a fourfold neuropathological classification correlating with genotype. There have been few fine structural
studies of these inclusions. Thus, we undertook an immunoelectron microscopic study of FTLD with TDP-43 proteinopathy, including
sporadic and familial cases with progranulin (GRN) mutation. TDP-43-immunoreactive inclusions comprised two components: granular and filamentous. Filament widths, expressed
as mean (range) were: NCI, 9 nm (4–16 nm); DN, 10 nm (5–16 nm); NII, 18 nm (9–50 nm). Morphologically distinct inclusion components
may reflect the process of TDP-43 aggregation and interaction with other proteins: determining these latter may contribute
towards understanding the heterogeneous pathogenesis of FTLD with TDP-43 proteinopathy.
Supported by grants to JRT and NJC from the Wellcome Trust (GR066166AIA), and National Institute on Aging of the National
Institutes of Health (P50 AG05681 and P01 AG03991) to NJC. 相似文献
30.
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series 总被引:1,自引:0,他引:1
Borroni B Archetti S Alberici A Agosti C Gennarelli M Bigni B Bonvicini C Ferrari M Bellelli G Galimberti D Scarpini E Di Lorenzo D Caimi L Caltagirone C Di Luca M Padovani A 《Neurogenetics》2008,9(3):197-205
Frontotemporal lobar degeneration (FTLD) recognises high familial incidence, with up to 50% of patients reported to have a family history of similar dementia. It has been reported that mutations within progranulin (PGRN) gene are a major cause of FTLD in the USA and worldwide, counting for 5-10% of FTLD and for 20-25% of familiar FTLD cases. The aim of the present study was to define the role of PGRN genetic variations in a large sample of consecutive patients with FTLD in Italy. Two-hundred forty-three FTLD patients were investigated. Each subject performed a clinical and neuropsychological evaluation, a functional and structural brain imaging, and the diagnosis was confirmed by at least 1 year follow-up. PGRN sequencing was performed in all FTLD patients and in 121 healthy age-matched controls drawn from the same geographic area. Only one PGRN pathogenetic mutation was found, consisting of a four-base pair deletion in the coding sequence of exon 8 (delCACT). This mutation was recognised in four patients, being the overall frequency of mutations in our clinical series of 1.64%. Considering only patients with a well-known family history for dementia, the frequency of this mutation was 6%. Moreover, four missense mutations within intron regions (g.100474G>A, g.100674G>A, g.101266G>A, g.102070G>A) were found. The frequency of these genetic variations did not differ in patients compared to controls, and they did not influence on clinical FTLD phenotype. In conclusion, this study supports a lower frequency of PGRN mutations amongst FTLD patients in Italy compared to literature data and further underlies the genetic heterogeneity of FTLD. 相似文献